Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Partial Shoulder Endoprosthesis — Cost, Top Hospitals & Success Rates | MyMedicPlus

Updated: 2026-07-07
Ad — after-intro

Quick Facts

Procedure Type
Partial shoulder joint replacement (hemiarthroplasty)
Anaesthesia
General or regional (interscalene nerve block)
Duration
1.5–3 hours
Hospital Stay
2–4 days
Recovery
3–6 months for full functional return
Success Rate
80–90% good-to-excellent pain relief
Last Reviewed
2026-06-26
Reviewer
MyMedicPlus Medical Review Board

Overview

A partial shoulder endoprosthesis, also called shoulder hemiarthroplasty, is an orthopaedic procedure in which only the humeral head (the ball of the upper-arm bone) is replaced with a metal implant, while the natural glenoid socket of the shoulder blade is preserved. This contrasts with total shoulder arthroplasty, which resurfaces both articulating surfaces.

The shoulder is the most mobile joint in the human body, relying on a complex interaction of the rotator cuff tendons, labrum, and bony anatomy. When the humeral head is severely damaged — through fracture, bone death, or advanced arthritis — a partial prosthesis can restore the joint's biomechanics and dramatically reduce pain.

Modern implant systems use anatomic or reverse configurations depending on rotator cuff integrity. Anatomic hemiarthroplasty mimics the natural humeral head geometry; reverse-design stems are considered when the rotator cuff is compromised. Surgical navigation and patient-specific implant sizing have improved outcomes significantly over the past decade.

The procedure is performed through a deltopectoral approach under general or regional anaesthesia and typically requires a 2–4 day hospital admission.

This procedure is offered at internationally accredited hospitals across India, Thailand, Turkey, and Mexico, where patients can access world-class surgical expertise at substantially lower costs than in the United States, the United Kingdom, or Australia, without compromising on clinical quality or patient safety outcomes.

Conditions Treated

Partial shoulder endoprosthesis is indicated when the humeral head is irreparably damaged but the glenoid remains relatively intact. Principal indications include:

  • Complex proximal humerus fractures: Neer 3- and 4-part fractures in elderly patients where internal fixation is unlikely to succeed due to poor bone stock or head-split patterns.
  • Avascular necrosis (AVN) of the humeral head: Bone death caused by corticosteroid therapy, excessive alcohol use, sickle-cell disease, or post-traumatic ischaemia.
  • Humeral head tumours: Select cases where limb-salvage surgery with oncologic resection is feasible.
  • Failed internal fixation: Non-union or malunion after plating or intramedullary nailing of proximal humerus fractures.
  • Glenohumeral osteoarthritis with glenoid bone loss: Cases where glenoid resurfacing is not possible due to inadequate socket bone stock.
  • Rotator cuff arthropathy: In combination with a reverse-stem design when the cuff is massively torn and irreparable.

Patient Eligibility

Candidate selection requires careful clinical and imaging assessment. Suitable candidates generally meet these criteria:

  • Severe shoulder pain or functional limitation not resolved by conservative management (physiotherapy, corticosteroid injections, analgesics) for at least 3–6 months
  • Radiographic evidence of humeral head destruction, collapse, or fracture not amenable to fixation
  • Adequate glenoid bone stock and cartilage to support a prosthetic humeral head
  • Functional rotator cuff (for anatomic hemiarthroplasty) or irreparable cuff tear (indicating reverse design consideration)
  • Realistic expectations and ability to participate in post-operative rehabilitation

Contraindications include active shoulder joint infection, brachial plexus palsy, severe neuromuscular disease affecting the shoulder girdle, and uncontrolled systemic illness that makes surgery unsafe.

Age consideration: Hemiarthroplasty is often preferred over total shoulder replacement in younger, active patients to preserve bone stock and allow future revision options.

Treatment Options

The orthopaedic surgeon will select the most appropriate implant design based on the patient's anatomy, rotator cuff status, and underlying diagnosis:

Anatomic Hemiarthroplasty

A metallic humeral stem with an anatomically shaped head articulates against the native glenoid cartilage. This option preserves maximum natural tissue and is preferred when the rotator cuff is intact. Modern systems use modular humeral heads that allow intraoperative sizing adjustments.

Humeral Resurfacing Arthroplasty

A bone-conserving option that caps the humeral head rather than replacing the entire stem. Suitable for younger patients with focal humeral head disease (e.g., early AVN) and good bone quality. Preserves more native bone for potential future revision.

Reverse Hemiarthroplasty (Proximal Humeral Replacement)

When the rotator cuff is massively torn or in tumour-reconstruction cases, a reverse-geometry stem with a convex glenosphere-shaped humeral cup can be used. The deltoid muscle assumes primary elevation function. Outcomes for pain relief are excellent; active elevation commonly reaches 90–120°.

Stemless Humeral Implants

Newer generation stemless designs achieve fixation entirely within the epiphysis without a medullary stem. They reduce bone removal and may simplify future revision, though long-term data beyond 10 years are still accumulating.

The surgeon will discuss implant choice, risks, and expected outcomes prior to scheduling surgery.

The selection of treatment approach follows a systematic assessment of clinical factors, patient preferences, and risk-benefit considerations. Evidence-based guidelines from professional societies including WHO, NICE, and relevant specialty organisations inform treatment selection and protocol design. Combination treatment strategies are increasingly favoured where multiple modalities provide synergistic benefit. The sequence and intensity of treatment components are titrated based on patient response at defined assessment intervals. Patients not responding adequately to initial treatment undergo structured reassessment to identify alternative approaches or combination strategies. Personalised medicine approaches using biomarker profiling and genetic analysis are emerging as tools to predict treatment response and guide individualised treatment selection in eligible patients. Multidisciplinary team review ensures all relevant clinical expertise informs treatment decisions for complex cases.

Benefits

Partial shoulder endoprosthesis offers substantial advantages for appropriately selected patients:

  • Significant pain relief: 80–90% of patients report good-to-excellent pain scores at 2 years, with many achieving near-complete pain resolution.
  • Improved range of motion: Forward flexion typically recovers to 100–130°; external rotation improves considerably, particularly with anatomic designs.
  • Glenoid bone preservation: Avoiding glenoid resurfacing maintains native socket bone stock, which is critical if future conversion to total shoulder replacement becomes necessary.
  • Durability: Well-fixed humeral stems demonstrate 10–15-year survival rates of 85–95% in registry data.
  • Lower surgical complexity than total shoulder: Shorter operative time and reduced risk of glenoid-component loosening, which is the leading cause of revision in total shoulder arthroplasty.
  • Quicker recovery in fracture patients: In elderly patients with complex proximal humerus fractures, early joint replacement avoids the prolonged immobilisation and high re-operation rates associated with open reduction and internal fixation.

Risks and Complications

As with all major joint surgery, partial shoulder endoprosthesis carries procedural and long-term risks that must be discussed with the surgeon:

Early Complications

  • Infection: Periprosthetic infection occurs in 0.5–2% of cases. Risk is higher in patients with diabetes, obesity, or immunosuppression.
  • Nerve injury: The axillary nerve runs near the surgical field; transient neurapraxia (weakness over the deltoid) is reported in up to 4% of cases and usually resolves within 6 months.
  • Bleeding and haematoma: Requiring post-operative drainage in rare cases.
  • Implant malpositioning: Incorrect version or height can impair rotator cuff mechanics and cause pain.

Late Complications

  • Glenoid erosion (medialisation): The most common long-term complication of hemiarthroplasty — the metal head may gradually erode the native glenoid cartilage, causing pain recurrence in 10–20% of patients at 10 years.
  • Aseptic loosening: Stem loosening requiring revision in 2–5% of cases over 10 years.
  • Rotator cuff tear: Post-operative cuff failure can limit functional recovery.
  • Stiffness: Adhesive capsulitis-like scarring reduces range of motion in approximately 5–8% of patients.

Most complications are manageable, and revision to total shoulder replacement is possible if glenoid erosion becomes symptomatic.

Recovery and Follow-Up

Structured rehabilitation is essential for optimal outcomes after partial shoulder endoprosthesis.

Immediate Post-Operative Phase (Week 1–3)

The arm is immobilised in a sling for 3–6 weeks depending on soft-tissue repair required during surgery. Passive pendulum exercises and gentle elbow/wrist range-of-motion begin within 24–48 hours to minimise stiffness.

Early Rehabilitation Phase (Week 3–8)

Passive and active-assisted shoulder range-of-motion exercises are commenced under physiotherapy guidance. Forward flexion, external rotation, and internal rotation are progressively restored. Patients typically regain the ability to perform light daily activities (eating, grooming) within 4–6 weeks.

Active Strengthening Phase (Week 8–16)

Isometric and then isotonic rotator cuff and periscapular strengthening exercises begin. Overhead activities are reintroduced gradually. Most patients can drive at 6–8 weeks post-operatively.

Functional Recovery (3–6 Months)

Full functional recovery, including return to recreational sport or moderate physical work, typically occurs between 3 and 6 months. Heavy manual labour or contact sports may require 9–12 months and are not always achievable.

Long-Term Follow-Up

Annual or biennial clinical and radiographic review is recommended to monitor for glenoid erosion and implant position. Patients should report any new onset shoulder pain or swelling promptly.

Cost Factors

The cost of partial shoulder endoprosthesis varies widely depending on geography, hospital tier, implant selection, and length of hospital stay. Key factors include:

  • Implant system: Standard modular stems cost less than premium stemless or patient-specific implants. Implant alone may account for 30–50% of total surgical cost.
  • Hospital setting: Private hospitals and academic medical centres typically charge more than community hospitals.
  • Anaesthesia type: General anaesthesia vs. regional nerve block combinations affect theatre and recovery-room time.
  • Physiotherapy: Supervised rehabilitation (12–20 sessions over 3–4 months) adds a meaningful portion to total cost.
  • Country of treatment: Patients seeking treatment abroad can save significantly. Costs in India, Thailand, and Turkey are typically 50–70% lower than in the United States or United Kingdom while maintaining internationally accredited surgical standards.

Insurance coverage varies; most policies covering orthopaedic surgery for medically necessary indications will cover hemiarthroplasty. Cosmetic or elective enhancement indications are generally excluded. Request itemised quotes from hospitals and confirm implant brand and generation before committing.

Alternatives to Partial Shoulder Endoprosthesis

Depending on the underlying diagnosis and patient profile, several alternatives may be considered:

  • Total shoulder arthroplasty (anatomic TSA): Replaces both the humeral head and the glenoid socket. Offers superior long-term pain relief in glenohumeral osteoarthritis but has higher revision risk due to potential glenoid loosening.
  • Reverse total shoulder arthroplasty (rTSA): Indicated for rotator-cuff-deficient shoulders. The ball-and-socket geometry is inverted; the deltoid compensates for the absent cuff. Increasingly used as first-line for elderly patients with complex fractures.
  • Open reduction and internal fixation (ORIF): For younger patients with better bone quality and reducible fracture patterns. Avoids prosthesis but carries higher re-operation rates in complex 4-part fractures.
  • Non-surgical management: In elderly low-demand patients, sling immobilisation and analgesia can provide acceptable functional outcomes for some fracture patterns, avoiding surgical risk entirely.
  • Arthroscopic debridement: In early AVN or mild glenohumeral arthritis, arthroscopic joint lavage and debridement may provide temporary symptom relief, deferring replacement by 2–5 years in selected patients.

Frequently Asked Questions

In a partial shoulder replacement (hemiarthroplasty), only the humeral head (ball) is replaced with a metal implant while the natural glenoid socket is preserved. A total shoulder replacement resurfaces both the ball and the socket. Partial replacement is preferred when the glenoid cartilage is still healthy, when glenoid bone stock is insufficient for socket fixation, or in younger patients who may need revision surgery in the future.
Registry data show that 85–95% of well-fixed humeral stems remain functional at 10–15 years. The main limitation is progressive erosion of the native glenoid cartilage by the metal head (medialisation), which can cause pain recurrence over time and may necessitate conversion to a total shoulder replacement. Patients who protect the joint by avoiding excessive loading have better long-term outcomes.
Most patients recover functional range of motion sufficient for daily activities including reaching above shoulder height, dressing, and personal hygiene. Achieving full, symmetric range of motion comparable to a healthy opposite shoulder is less predictable and depends on rotator cuff integrity, pre-operative stiffness, implant positioning, and adherence to physiotherapy. Overhead athletes may not fully return to pre-injury performance levels.
Post-operative pain is well controlled with multi-modal analgesia including nerve blocks, non-steroidal anti-inflammatory drugs, and acetaminophen. Most patients experience moderate discomfort for the first 2–4 weeks that resolves progressively. The majority report significant improvement in chronic shoulder pain compared to their pre-operative state by 6–12 weeks after surgery.
Partial replacement is generally preferred when: (1) the glenoid socket cartilage is largely intact, (2) glenoid bone stock is inadequate for socket fixation, (3) the patient is young and a second operation (revision) may eventually be needed, or (4) the diagnosis is an acute proximal humerus fracture where glenoid resurfacing is not required. Total shoulder replacement provides more predictable pain relief in glenohumeral osteoarthritis with glenoid involvement.

References

  1. Rasmussen JV, et al. Current status of shoulder arthroplasty: what do we know? A systematic review. Acta Orthopaedica. 2020;91(5):531-537.
  2. Boileau P, Walch G. The three-dimensional geometry of the proximal humerus. Implications for surgical technique and prosthetic design. Journal of Bone and Joint Surgery (Br). 1997;79(5):857-865.
  3. Orfaly RM, et al. A prospective functional outcome study of shoulder arthroplasty for osteoarthritis with an intact rotator cuff. Journal of Shoulder and Elbow Surgery. 2003;12(3):214-221.
  4. Court-Brown CM, et al. The epidemiology of proximal humeral fractures. Acta Orthopaedica Scandinavica. 2001;72(4):365-371.
  5. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). Annual Report 2023. Hip, Knee & Shoulder Arthroplasty.
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-07-07

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.